|
|
|
|
Дата |
|---|
| 02.02.2026 |
| 01.02.2026 |
| 29.01.2026 |
| 28.01.2026 |
| 27.01.2026 |
| 26.01.2026 |
| 22.01.2026 |
| 21.01.2026 |
| 20.01.2026 |
| 19.01.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
79.48
|
78.31
|
79.96
|
78.50
|
|
|
21 187 162.07
|
345.00
|
|
|
|
77.41
|
77.10
|
79.99
|
79.48
|
|
|
32 080 930.12
|
771.00
|
|
|
|
78.50
|
76.60
|
79.44
|
77.41
|
|
|
11 605 449.94
|
539.00
|
|
|
|
78.50
|
76.60
|
79.44
|
77.41
|
|
|
11 605 449.94
|
539.00
|
|
|
|
79.45
|
78.02
|
80.94
|
78.50
|
|
|
18 167 224.08
|
726.00
|
|
|
|
77.50
|
77.05
|
79.45
|
79.45
|
|
|
31 315 967.43
|
507.00
|
|
|
|
79.99
|
78.14
|
79.99
|
78.25
|
|
|
15 223 716.94
|
607.00
|
|
|
|
78.90
|
77.50
|
79.99
|
79.99
|
|
|
9 902 315.04
|
400.00
|
|
|
|
78.89
|
78.07
|
79.49
|
78.90
|
|
|
27 289 182.91
|
362.00
|
|
|
|
77.19
|
76.73
|
79.00
|
78.89
|
|
|
32 329 581.94
|
660.00
|
Период |
|---|
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
